Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Hemoglobin|May 24, 2011
1-(2-Hydroxyethoxy) methyl-2-methyl-3-hydroxyl-4-pyridinone: a targeted, bifunctional chelating agent for potential uranic detoxification in the kidneyGang Liu, Ping Men, Gerry H KennerHealth Physics|June 22, 2002
An EPR model for separating internal 90Sr doses from external gamma-ray doses in teethRobert B Hayes, Edwin H Haskell, Gerry H KennerHemoglobin|February 16, 2008
Therapeutic effects of an oral chelator targeting skeletal tissue damage in experimental postmenopausal osteoporosis in ratsGang Liu, Ping Men, Gerry H Kenner, et al.Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine|May 13, 2006
Age-associated iron accumulation in bone: implications for postmenopausal osteoporosis and a new target for prevention and treatment by chelationGang Liu, Ping Men, Gerry H Kenner, et al.Nucleosides, Nucleotides & Nucleic Acids|April 29, 2004
Acyclonucleoside iron chelators of 1-(2-hydroxyethoxy)methyl-2-alkyl-3-hydroxy-4-pyridinones: potential oral iron chelation therapeuticsGang Liu, Ping Men, Gerry H Kenner, et al.Pageof 1